These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34631744)

  • 41. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
    Denning DW; Cadranel J; Beigelman-Aubry C; Ader F; Chakrabarti A; Blot S; Ullmann AJ; Dimopoulos G; Lange C;
    Eur Respir J; 2016 Jan; 47(1):45-68. PubMed ID: 26699723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A clinican linical analysis of 29 cases of chronic pulmonary aspergillosis].
    Xu LY; Lai GX; Hu Q; Zhang L; Liu DL; Zhu GB; Li XH; Shi HH; Xu C; Yu YH; Bao YW; Chen W
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Feb; 41(2):100-104. PubMed ID: 29429215
    [No Abstract]   [Full Text] [Related]  

  • 43. Editor's Highlight: Prospective Analyses of Volatile Organic Compounds in Obstructive Sleep Apnea Patients.
    Aoki T; Nagaoka T; Kobayashi N; Kurahashi M; Tsuji C; Takiguchi H; Tomomatsu K; Oguma T; Kobayashi N; Magatani K; Takeda S; Asano K; Abe T
    Toxicol Sci; 2017 Apr; 156(2):362-374. PubMed ID: 28003437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of metabolomic profiles obtained using chemical ionization and electron ionization MS in exhaled breath.
    Turner MA; Guallar-Hoyas C; Kent AL; Wilson ID; Thomas CL
    Bioanalysis; 2011 Dec; 3(24):2731-8. PubMed ID: 22185273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter Evaluation of a Novel Immunochromatographic Test for Anti-aspergillus IgG Detection.
    Piarroux RP; Romain T; Martin A; Vainqueur D; Vitte J; Lachaud L; Gangneux JP; Gabriel F; Fillaux J; Ranque S
    Front Cell Infect Microbiol; 2019; 9():12. PubMed ID: 30766842
    [No Abstract]   [Full Text] [Related]  

  • 47. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles.
    Koyama K; Ohshima N; Suzuki J; Kawashima M; Takeda K; Ando T; Sato R; Nagai H; Matsui H; Ohta K
    J Infect Chemother; 2014 Jun; 20(6):375-9. PubMed ID: 24679654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
    van Mastrigt E; de Jongste JC; Pijnenburg MW
    Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is There an Overlap in Immune Response Between Allergic Bronchopulmonary and Chronic Pulmonary Aspergillosis?
    Sehgal IS; Choudhary H; Dhooria S; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):969-974. PubMed ID: 30205191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary electrospray ionization-mass spectrometry and a novel statistical bioinformatic approach identifies a cancer-related profile in exhaled breath of breast cancer patients: a pilot study.
    Martinez-Lozano Sinues P; Landoni E; Miceli R; Dibari VF; Dugo M; Agresti R; Tagliabue E; Cristoni S; Orlandi R
    J Breath Res; 2015 Sep; 9(3):031001. PubMed ID: 26390050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics and outcomes of chronic pulmonary aspergillosis: a retrospective analysis of a tertiary hospital registry.
    Camara B; Reymond E; Saint-Raymond C; Roth H; Brenier-Pinchart MP; Pinel C; Cadranel J; Ferretti G; Pelloux H; Pison C;
    Clin Respir J; 2015 Jan; 9(1):65-73. PubMed ID: 24406138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.
    Meyer N; Dallinga JW; Nuss SJ; Moonen EJ; van Berkel JJ; Akdis C; van Schooten FJ; Menz G
    Respir Res; 2014 Nov; 15(1):136. PubMed ID: 25431084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
    Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
    J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.
    Zetola NM; Modongo C; Matsiri O; Tamuhla T; Mbongwe B; Matlhagela K; Sepako E; Catini A; Sirugo G; Martinelli E; Paolesse R; Di Natale C
    J Infect; 2017 Apr; 74(4):367-376. PubMed ID: 28017825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.